Target Name: CAMK1D
NCBI ID: G57118
Review Report on CAMK1D Target / Biomarker Content of Review Report on CAMK1D Target / Biomarker
CAMK1D
Other Name(s): KCC1D_HUMAN | CAMK1D variant 2 | OTTHUMP00000019120 | Calcium/calmodulin-dependent protein kinase type 1D | calcium/calmodulin dependent protein kinase ID | CaM-K1 | CaM kinase ID | CaM kinase I delta | caMKI delta | caM kinase I delta | CamKI-like protein kinase | OTTHUMP00000045030 | CaMKI-like protein kinase | caM-KI delta | Calcium/calmodulin dependent protein kinase ID, transcript variant 2 | CKLiK | CAMK1D/ANAPC5 fusion | CaMKI-delta | Calcium/calmodulin-dependent protein kinase type 1D (isoform 2) | Camk1D | OTTHUMP00000019119 | Calcium/calmodulin-dependent protein kinase ID | CaM-KI delta | CaMKID | CaMKI delta

CAMK1D as A Potential Drug Target for Neurodegenerative Diseases

CAMK1D (KCC1D_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and muscle. It is a key regulator of the myelin sheath that surrounds the nerve fibers, and it is involved in the development and maintenance of normal nervous system function.

Recent studies have identified CAMK1D as a potential drug target for a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. This is because the disruption of CAMK1D has been observed to contribute to the pathophysiology of these conditions, and because the activity of CAMK1D has been shown to be involved in the progression of these diseases.

One of the key mechanisms by which CAMK1D is involved in the development of neurodegenerative diseases is its role in the regulation of the microtubules of neurons. Microtubules are the structural scaffolding that organize the cells of neurons, and they are involved in the transport of neurotransmitters , the regulation of ion channels, and other important cellular processes. The misfolding of microtubules, which can occur due to various factors, including protein disruptions, has been implicated in the development of neurodegenerative diseases.

CAMK1D is specifically involved in the regulation of microtubules of the type IIB, which are composed of the protein T-tubin and the protein p180. T-tubin is a protein that is derived from the alpha-tubulin protein, which is a key component of microtubules. P180 is a non-histone protein that is involved in the regulation of microtubule dynamics.

Studies have shown that the misfolding of T-tubin and P180 can contribute to the formation of aggregates that disrupt microtubules and contribute to the development of neurodegenerative diseases. In addition, CAMK1D has been shown to play a role in the regulation of microtubule dynamics in a variety of cell types, including neurons, astrocytes, and oligodendrocytes.

In addition to its role in the regulation of microtubules, CAMK1D is also involved in the regulation of the cytoskeleton, which is the structural scaffolding that organizes the cytoplasm of cells. The cytoskeleton is composed of a variety of proteins that help to maintain the shape and stability of the cell, and it is involved in a wide range of cellular processes, including cell division, migration, and the regulation of mechanical forces.

Studies have shown that the cytoskeleton plays a critical role in the regulation of neuronal function, and that alterations in the cytoskeleton can contribute to the development of neurodegenerative diseases. In addition, CAMK1D has been shown to be involved in the regulation of the cytoskeleton in a variety of cell types, including neurons, and it has been implicated in the development of neurodegenerative diseases.

Given the involvement of CAMK1D in the regulation of microtubules and the cytoskeleton, it is a potential drug target for a variety of neurological and psychiatric disorders. Studies have shown that the disruption of CAMK1D has been observed to contribute to the pathophysiology of conditions such as Alzheimer's disease, Parkinson's disease, and depression, and that the activity of CAMK1D has been shown to be involved in the progression of these conditions.

In addition to its potential as a drug target, CAMK1D is also a potential biomarker for the development of neurodegenerative diseases. The disruption of CAMK1D has been observed to contribute to the development of neurodegenerative diseases, and studies have shown that the levels of CAMK1D are often decreased in the brains of individuals with neurodegenerative

Protein Name: Calcium/calmodulin Dependent Protein Kinase ID

Functions: Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Activates the transcription factor CREB1 in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells. In vitro, phosphorylates transcription factor CREM isoform Beta

The "CAMK1D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAMK1D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CAMK1G | CAMK2A | CAMK2B | CAMK2D | CAMK2G | CAMK2N1 | CAMK2N2 | CAMK4 | CAMKK1 | CAMKK2 | CAMKMT | CAMKV | CAMLG | CAMP | cAMP Phosphodiesterase | cAMP Responsive Element Binding Protein (CREB) | cAMP-Dependent protein kinase (PKA) | CAMSAP1 | CAMSAP2 | CAMSAP3 | CAMTA1 | CAMTA2 | CAND1 | CAND1.11 | CAND2 | Cannabinoid receptor | CANT1 | CANX | Cap-binding complex | CAP1 | CAP2 | CAPG | CAPN1 | CAPN10 | CAPN10-DT | CAPN11 | CAPN12 | CAPN13 | CAPN14 | CAPN15 | CAPN2 | CAPN3 | CAPN5 | CAPN6 | CAPN7 | CAPN8 | CAPN9 | CAPNS1 | CAPNS2 | CAPRIN1 | CAPRIN2 | CAPS | CAPS2 | CAPSL | CAPZA1 | CAPZA2 | CAPZA3 | CAPZB | Carbonic Anhydrase | Carbonic Anhydrase V | Carboxylesterase | Carboxypeptidase A | Carboxypeptidase B | Carboxypeptidase N | Carcinoembryonic Antigen-Related Cell Adhesion Molecule (CEA) | CARD10 | CARD11 | CARD14 | CARD16 | CARD17P | CARD18 | CARD19 | CARD6 | CARD8 | CARD8-AS1 | CARD9 | Cardiac Troponin | CARF | CARHSP1 | CARM1 | CARMAL | CARMIL1 | CARMIL2 | CARMIL3 | CARMN | Carnitine O-Palmitoyltransferase (CPT) | Carnitine O-Palmitoyltransferase 1 (CPT-1) | Carnitine O-palmitoyltransferase 2 | CARNMT1 | CARNS1 | CARS1 | CARS1-AS1 | CARS2 | CARTPT | CASC11 | CASC15 | CASC16 | CASC17 | CASC18 | CASC19